The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Measles Vaccine Market Research Report 2024

Global Measles Vaccine Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1888260

No of Pages : 89

Ask Your Query

Synopsis

The global Measles Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs.

However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Measles Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Measles Vaccine.

Report Scope

The Measles Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Measles Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Measles Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • GSK
  • Sanofi-Pasteur
  • Merck
  • Novartis
  • Pfizer
  • Serum Institute of India
  • China National Biotech Group
  • Bavarian Nordic
  • Emergent Biosolutions
  • Medimmune
  • Johnson & Johnson
  • CSL Limited

Segment by Type

  • Mumps Measles Rubella Vaccine, Live (MMR-II)
  • Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)

Segment by Application

  • Children
  • Adults

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Measles Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Measles Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Measles Vaccine Market Overview
1.1 Product Overview and Scope of Measles Vaccine
1.2 Measles Vaccine Segment by Type
1.2.1 Global Measles Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Mumps Measles Rubella Vaccine, Live (MMR-II)
1.2.3 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
1.3 Measles Vaccine Segment by Application
1.3.1 Global Measles Vaccine Market Value by Application: (2024-2030)
1.3.2 Children
1.3.3 Adults
1.4 Global Measles Vaccine Market Size Estimates and Forecasts
1.4.1 Global Measles Vaccine Revenue 2019-2030
1.4.2 Global Measles Vaccine Sales 2019-2030
1.4.3 Global Measles Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Measles Vaccine Market Competition by Manufacturers
2.1 Global Measles Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Measles Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Measles Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Measles Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Measles Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Measles Vaccine, Product Type & Application
2.7 Measles Vaccine Market Competitive Situation and Trends
2.7.1 Measles Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Measles Vaccine Players Market Share by Revenue
2.7.3 Global Measles Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Measles Vaccine Retrospective Market Scenario by Region
3.1 Global Measles Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Measles Vaccine Global Measles Vaccine Sales by Region: 2019-2030
3.2.1 Global Measles Vaccine Sales by Region: 2019-2024
3.2.2 Global Measles Vaccine Sales by Region: 2025-2030
3.3 Global Measles Vaccine Global Measles Vaccine Revenue by Region: 2019-2030
3.3.1 Global Measles Vaccine Revenue by Region: 2019-2024
3.3.2 Global Measles Vaccine Revenue by Region: 2025-2030
3.4 North America Measles Vaccine Market Facts & Figures by Country
3.4.1 North America Measles Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Measles Vaccine Sales by Country (2019-2030)
3.4.3 North America Measles Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Measles Vaccine Market Facts & Figures by Country
3.5.1 Europe Measles Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Measles Vaccine Sales by Country (2019-2030)
3.5.3 Europe Measles Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Measles Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Measles Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Measles Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Measles Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Measles Vaccine Market Facts & Figures by Country
3.7.1 Latin America Measles Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Measles Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Measles Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Measles Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Measles Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Measles Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Measles Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Measles Vaccine Sales by Type (2019-2030)
4.1.1 Global Measles Vaccine Sales by Type (2019-2024)
4.1.2 Global Measles Vaccine Sales by Type (2025-2030)
4.1.3 Global Measles Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Measles Vaccine Revenue by Type (2019-2030)
4.2.1 Global Measles Vaccine Revenue by Type (2019-2024)
4.2.2 Global Measles Vaccine Revenue by Type (2025-2030)
4.2.3 Global Measles Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Measles Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Measles Vaccine Sales by Application (2019-2030)
5.1.1 Global Measles Vaccine Sales by Application (2019-2024)
5.1.2 Global Measles Vaccine Sales by Application (2025-2030)
5.1.3 Global Measles Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Measles Vaccine Revenue by Application (2019-2030)
5.2.1 Global Measles Vaccine Revenue by Application (2019-2024)
5.2.2 Global Measles Vaccine Revenue by Application (2025-2030)
5.2.3 Global Measles Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Measles Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Measles Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Sanofi-Pasteur
6.2.1 Sanofi-Pasteur Corporation Information
6.2.2 Sanofi-Pasteur Description and Business Overview
6.2.3 Sanofi-Pasteur Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi-Pasteur Measles Vaccine Product Portfolio
6.2.5 Sanofi-Pasteur Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Measles Vaccine Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Measles Vaccine Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Measles Vaccine Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Serum Institute of India
6.6.1 Serum Institute of India Corporation Information
6.6.2 Serum Institute of India Description and Business Overview
6.6.3 Serum Institute of India Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Serum Institute of India Measles Vaccine Product Portfolio
6.6.5 Serum Institute of India Recent Developments/Updates
6.7 China National Biotech Group
6.6.1 China National Biotech Group Corporation Information
6.6.2 China National Biotech Group Description and Business Overview
6.6.3 China National Biotech Group Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 China National Biotech Group Measles Vaccine Product Portfolio
6.7.5 China National Biotech Group Recent Developments/Updates
6.8 Bavarian Nordic
6.8.1 Bavarian Nordic Corporation Information
6.8.2 Bavarian Nordic Description and Business Overview
6.8.3 Bavarian Nordic Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bavarian Nordic Measles Vaccine Product Portfolio
6.8.5 Bavarian Nordic Recent Developments/Updates
6.9 Emergent Biosolutions
6.9.1 Emergent Biosolutions Corporation Information
6.9.2 Emergent Biosolutions Description and Business Overview
6.9.3 Emergent Biosolutions Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Emergent Biosolutions Measles Vaccine Product Portfolio
6.9.5 Emergent Biosolutions Recent Developments/Updates
6.10 Medimmune
6.10.1 Medimmune Corporation Information
6.10.2 Medimmune Description and Business Overview
6.10.3 Medimmune Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Medimmune Measles Vaccine Product Portfolio
6.10.5 Medimmune Recent Developments/Updates
6.11 Johnson & Johnson
6.11.1 Johnson & Johnson Corporation Information
6.11.2 Johnson & Johnson Measles Vaccine Description and Business Overview
6.11.3 Johnson & Johnson Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Johnson & Johnson Measles Vaccine Product Portfolio
6.11.5 Johnson & Johnson Recent Developments/Updates
6.12 CSL Limited
6.12.1 CSL Limited Corporation Information
6.12.2 CSL Limited Measles Vaccine Description and Business Overview
6.12.3 CSL Limited Measles Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 CSL Limited Measles Vaccine Product Portfolio
6.12.5 CSL Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Measles Vaccine Industry Chain Analysis
7.2 Measles Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Measles Vaccine Production Mode & Process
7.4 Measles Vaccine Sales and Marketing
7.4.1 Measles Vaccine Sales Channels
7.4.2 Measles Vaccine Distributors
7.5 Measles Vaccine Customers
8 Measles Vaccine Market Dynamics
8.1 Measles Vaccine Industry Trends
8.2 Measles Vaccine Market Drivers
8.3 Measles Vaccine Market Challenges
8.4 Measles Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock